Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Bullboard Posts
Comment by Ineedmoneyxxxon Apr 13, 2019 5:09am
53 Views
Post# 29622245

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Lets talk post licence

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Lets talk post licence
GrahamB wrote: All good points
I also didn’t consider the oils they are going to extract
I didn't for 2 reasons;
1. The main reason, is this company so far has been making  promises, and I want to know what their likely profits are going to be in the next few months the next quarter 
2.The  Side deals are hard to value, and also hard to know if and when they will be actualized. 
 That is, they are acting more like a hedge fund, where they buy into another company, and they own a portion of those profits. Those profits in turn,  are forecasted, and in many cases are based on potential.Take the algae project. This was a nonbinding letter of intent. They don’t even have a deal, the time has passed for the initial evaluation, and they still haven’t announced. Even if they get the deal it’s a concept, they haven’t even produced out of algae   
 To the point, this group has made forward-looking comments/promotional statements that have never come to fruition  whether it be regarding business(TPRX) or management (aHaynes)

 So my focus here, is to actually calculate what is likely to happen in the next quarter 
 I don’t need to think about the pie in the sky, because that’s all this company has done to this point  
 The problem is they haven’t executed, and I believe that a nave investor can get misled by all these promises 
 I want to be the biggest producer in the world 
 I want to be a leader in the medical marijuana category 
 I want to have patents with cutting edge therapeutics (because that’s where the profit is)
Yeah
 I want to be an astronaut 
 Problem is  I never did anything about it 

 So just for fun is it possible to determine what the actual profit will be in the next quarter or two 
 I think this is also important because it keeps us grounded in reality, instead of looking down the road, because that approach has not gotten us anywhere 
 At some point these companies will all be valued based on what they are actually producing, and importantly what kind of profits are making. Even though many of these companies are generating revenue, they are not making profit
 We may see a reevaluation of these companies, so it’s good to have a couple different projections, but the projections to the upside have already been made. Let’s look at what the real profit will be, as it grounds our speculation.

 Maybe I was just getting frustrated, but on reflection I still think it’s a good process 
 I think if we put together some numbers, and folks can chip in on what they think is realistic for putting down a number, we can come up with a range, and as a group it will be fun to see what they sit with they come up with 
 After all, there are no analysts here, and it seems to be a better use of our time thanpeople insulting something each other 
 Those who are optimists can state a high number, pessimists a lo one, and those of us that are realists make them in the middle 
All good in my books


first enjoy reading your posts on here. As far as determining value, currently the company can't be valued more than their existing assets less operation costs. Moving forward, aside from the license to sell limitations we would need to know production numbers, costs and established contracts in regards to distribution. Can't imagine us having the proper information soon. The potential here is killer and in all likelihood will be the grand enterprise that many here envision but not soon, IMO. No debt minimal operational costs, fingers in many pies GLTA
Bullboard Posts